Chronic Kidney Disease/Bone and Mineral Metabolism: The Imperfect Storm

被引:14
作者
Williams, Mark E. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
Kidney; mineral; hyperparathyroidism; vitamin D; TREAT SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE SECRETION; VITAMIN-D; DIETARY PHOSPHATE; SERUM PHOSPHORUS; ADYNAMIC BONE; FIBROBLAST-GROWTH-FACTOR-23; CALCIUM; CINACALCET; MODERATE;
D O I
10.1016/j.semnephrol.2009.01.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
As kidney function declines, chronic kidney disease (CKD) becomes an increasingly systemic disorder. Most patients with CKD eventually develop subclinical or clinical abnormalities in bone and mineral metabolism. Recent observational and basic scientific studies have led to a new emphasis on the changes in phosphorus and calcium metabolism, parathyroid hormone, and vitamin D that lead to this complex systemic bone/mineral disorder (CKD/BMD). At the center of the disorder are relationships among all 4 factors that conspire to create a perfect storm, leading to secondary hyperparathyroidism (SHPT). Some key current issues that are reviewed here are as follows: (1) factors promoting SHPT, (2) the role of fibroblast growth factor-23 in CKD/BMD, (3) molecular mechanisms of SHPT, (4) mechanisms of vascular calcification, and (5) medical management of the disorder, including calcimimetics. Current therapies directed at correcting the primary abnormalities (ie, improve conditions to an imperfect storm) and minimizing the consequences of CKD/BMD are discussed. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 59 条
[2]  
Almaden Y, 1998, J AM SOC NEPHROL, V9, P1845
[3]   Adynamic bone in patients with chronic kidney disease [J].
Andress, D. L. .
KIDNEY INTERNATIONAL, 2008, 73 (12) :1345-1354
[4]   Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation [J].
Andress, DL .
KIDNEY INTERNATIONAL, 2006, 69 (01) :33-43
[5]   EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease [J].
Arcidiacono, Maria Vittoria ;
Sato, Tetsuhiko ;
Alvarez-Hernandez, Daniel ;
Yang, Jing ;
Tokurl, Masanori ;
Gonzalez-Suarez, Ignacio ;
Lu, Yan ;
Tominaga, Yoshihiro ;
Cannata-Andia, Jorge ;
Slatopolsky, Eduardo ;
Dusso, Adriana S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (02) :310-320
[6]  
ARCIDIACONO MV, 2008, J AM SOC NEPHROL
[7]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[8]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[9]  
Bouillon R, 2008, J BONE MINER RES, V23, P974, DOI [10.1359/jbmr.080420, 10.1359/JBMR.080420]
[10]   Adynamic bone disease-bone and beyond [J].
Brandenburg, Vincent M. ;
Floege, Juergen .
CLINICAL KIDNEY JOURNAL, 2008, 1 (03) :135-147